The PCCI will develop software that can help clinicians predict patient problems before they occur, according to the release.
Ruben Amarasingham, MD, who has been named president and CEO of PCCI, has already worked with researchers to create a clinical decision support software system called PIECES to reduce readmission rates. Development of PIECES and other research has been funded by more than $4.5 million in competitive grant awards from institutions including the National Institutes of Health, The National Cancer Institute and the W.W. Caruth, Jr. Foundation of the Communities Foundation of Texas, according to the report.
More Articles on Clinical Decision Support:
Diagnostic Decision Support a ‘Must Have’ for Clinical and Financial Success in Value-Based World
Study: Community Hospitals Have Robust Levels of Clinical Decision Support
ONC Announces Clinical Decision Support, Interoperability Framework